Lecanemab Clears Amyloid by Activating Microglia
In a groundbreaking advancement poised to redefine Alzheimer’s disease therapy, researchers have unveiled compelling evidence that Lecanemab, a therapeutic antibody targeting amyloid-beta (Aβ) pathology, exerts...
















